Metrion Biosciences is a specialist preclinical drug discovery contract research organization (CRO) focussed on delivering a range of high quality ion channel, cardiac safety and neuroscience services. We provide highly skilled electrophysiology screening and high-throughput screening (HTS) services to support medicinal chemistry optimisation programmes, hERG screening, including GLP compliant hERG screening, plus CiPA compliant cardiac safety profiling assays, neuroscience assays, CNS and translational assays.

Working closely with collaborators, we also offer an expert integrated drug discovery service.

Business models are flexible according to the scope of each programme, with both fee-for-service and collaborative options available.

Metrion’s highly expert and dedicated specialists support diverse ion channel, cardiac safety and neuroscience drug discovery projects and modern safety assessment research. We combine in depth target class knowledge and high quality screening assays with experienced and collaborative project managers to keep your research focused upon meeting both objectives and timelines.